The data from these studies suggest that the SCD can be safely administered in critically ill AKI patient populations without adding additional safety risks. (8/8)

So proud to be working with such great minds in nephrology and critical care! stuart goldstein David Askenazi MD, MSPH Jay Koyner Raj Basu

SeaStar Medical will be holding investment community meetings Jan. 8-11 at J.P. Morgan Healthcare week in San Francisco. Join CEO, Eric Schlorff Eric Schlorff and CMO Kevin Chung, MD. Kevin K. Chung, MD For more information, contact Jody Cain at LHA Investor Relations: [email protected]

First Saban, now Belichick….wow!

So proud of our team! Big day for pediatric patients!

Watch the exciting and informative interview from our fearless leader, CEO Eric Schlorff Eric Schlorff as he discusses SeaStar Medical on the Big Biz Show! @sullyontheair @sullyspeaks BizTV BizTalkRadio Youtoo America

Big news from the Big Apple – read more from the official U.S. FDA website HERE: fda.gov/vaccines-blood… Thank you @nasdaq for the great shot! #fdaapproval #nasdaq #icu $ICU

Coming soon…..Cappuccino with Claudio featuring Dr. Humes and stuart goldstein discussing our SCD! #CRRT2024 #ICU $ICU

SeaStar is a proud sponsor of the 6th CKD Drug Development Summit, taking place March 19-21 in Boston. The CKD Summit is the premier forum bringing together key opinion leaders, industry partners and regulators focusing on the next generation of drug development in kidney

Moving on up…and amplifying #QUELimmune… One engagement at a time. ⁦SeaStarMedical #SCD $ICU

Cappuccino with Claudio Ronco: 366. Discovery and application of new sel... youtu.be/onRUqgYaRDA?si… via YouTube $ICU #SCD Kevin K. Chung, MD Sai Iyer Ph.D stuart goldstein

SeaStar’s own Kevin K. Chung, MD on this new episode of Critical Care Time podcast! #ICU $ICU #MedTwitter

New device can treat injury from sepsis | Michigan Medicine #SCDHDEinPeds #QUELimmune ⁦SeaStarMedical⁩ michiganmedicine.org/health-lab/new…

I love this dude…..could Listen to him talk all day.

SeaStar CEO, Eric Schlorff appears on the Big Biz Show to discuss our SCD technology and progress we're making to commercialize the QUELimmune pediatric device! Big things ahead!! #SCD $ICU #ICU Robert "Sully" Sullivan

Proud to be a part of this work!

New article in Nature Scientific Reports describes the mechanism of action of our novel SCD technology in combating the harmful effects of hyperinflammation. Take a👀. . . nature.com/articles/s4159…

BIG NEWS!!

A very big day in pediatric AKI, today we announce the FIRST pediatric patient is treated with our QUELIMMUNE therapy! investors.seastarmedical.com/news/news-deta…

We are now enrolling in our SAVE (SCD-PED) Pediatric Surveillance Registry!! Learn more here: clinicaltrials.gov/study/NCT06517…